HDAC INHIBITORS IN T-CELL LYMPHOMAS

被引：0
|
作者：
Coiffier, B. [1 ]
机构：
[1] Ctr Hosp Pierre Benite, Lyon, France
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
MULTICENTER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [1] HDAC inhibitors for the treatment of cutaneous T-cell lymphomas
    Rangwala, Sophia
    Zhang, Chunlei
    Duvic, Madeleine
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (04) : 471 - 486
  • [2] Histone Deacetylase Inhibitors for Peripheral T-Cell Lymphomas
    Irimia, Ruxandra
    Piccaluga, Pier Paolo
    CANCERS, 2024, 16 (19)
  • [3] Small molecule inhibitors for cutaneous T-cell lymphomas
    Alaibac, Mauro
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (05): : 345 - 350
  • [4] Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
    Lopez, Adriana T.
    Bates, Susan
    Geskin, Larisa
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (06) : 805 - 819
  • [5] Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
    Adriana T. Lopez
    Susan Bates
    Larisa Geskin
    American Journal of Clinical Dermatology, 2018, 19 : 805 - 819
  • [6] Erythrophagocytic T-cell lymphomas are hepatosplenic γδ T-cell lymphomas.
    Macon, WR
    Przybylski, GK
    Salhany, KE
    Choi, JK
    Kadin, ME
    LABORATORY INVESTIGATION, 1999, 79 (01) : 142A - 142A
  • [7] Expression of HAT1 and HDAC1, 2, 3 in Diffuse Large B-Cell Lymphomas, Peripheral T-Cell Lymphomas, and NK/T-Cell Lymphomas
    Min, Soo Kee
    Koh, Young Ho
    Park, Yunwoong
    Kim, Hyo Jung
    Seo, Jinwon
    Park, Hye-Rim
    Cho, Seong Jin
    Kim, In Sun
    KOREAN JOURNAL OF PATHOLOGY, 2012, 46 (02) : 142 - 150
  • [8] T-CELL LYMPHOMAS
    MIODUSZEWSKA, O
    ARCHIV FUR GESCHWULSTFORSCHUNG, 1979, 49 (08): : 685 - 693
  • [9] γδ T-cell lymphomas
    Gaulard, P
    Belhadj, K
    Reyes, F
    SEMINARS IN HEMATOLOGY, 2003, 40 (03) : 233 - 243
  • [10] T-CELL LYMPHOMAS
    WRIGHT, DH
    HISTOPATHOLOGY, 1986, 10 (03) : 321 - 326
12345